A recent review suggests that people currently or recently treated with benzodiazepines may have an increased risk of developing pneumonia. The research categorised usage into current exposure (within 30 days), recent use (within 31-90 days), and past use (beyond 90...
Researchers have recently analysed state registry data to provide nationwide estimates to elucidate the qualifying conditions for which patients are licensed to use cannabis medically. The research also compared the prevalence of medical cannabis qualifying conditions...
The use of individually compounded creams as a topical treatment for chronic pain has increased in popularity, perhaps in part because of a lack of effective options for pain management and also the toxicity profile of drugs prescribed by the oral route for this...
There is increasing concern about the dramatic rise in the prescribing of pregabalin in Australia and around the world. New research published in the Medical Journal of Australia has underlined this trend: The study examined pregabalin misuse‐related ambulance...
A study recently published in The Lancet has explored the possible influence of β-blockers upon the risk of COPD. In this huge study, researchers compared 301,542 new users of β-blockers to 1,000,633 new users of any other antihypertensive drugs (aged 30–90 years...
